MDCXW — Medicus Pharma Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1997296 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -14,460,256 -15,181,335 14,536,679 5,019,755 25,026,436
Jun 2026 0 — -11,478,789 -11,617,705 27,116,185 15,174,128 28,841,149
Mar 2026 0 — -8,597,077 -9,042,143 7,426,911 6,365,624 5,999,017
Dec 2025 0 — -7,790,600 -8,184,411 10,061,377 8,705,218 10,024,066

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-29,320,075
Investing CF
$0
Financing CF
$49,379,679
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-85,007,966
Inventory
—
Receivables
$14,000
ST Investments
—
EBIT TTM
$-43,363,328
Pretax Income TTM
$-44,892,607
Interest Exp TTM
$580,350
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -34,359,302 -35,444,215 10,061,377 10,024,066 -67,554 -22,776,769
Dec 2024 0 -11,180,902 -11,155,516 5,646,878 2,512,174 3,134,704 -10,247,231
Dec 2023 0 -2,658,365 -5,314,765 1,893,057 781,609 1,111,448 -4,158,264
Dec 2022 0 -978,416 -1,692,382 282,652 12,480,684 -12,198,032 -1,057,103

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-56,662,869
OpCashFlow TTM
—
Assets (Latest)
$27,116,185
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

Medicus Pharma raises $4.25M in CEO-led financings
2026-11-16 14:45 · Yahoo
Medicus Pharma Announces Closing of $4.25 Million CEO-Led Equity Financings and $10.5 Million Debt Exchange
2026-11-16 12:30 · Yahoo
Medicus Pharma shares rationale as CD228V becomes lead development priority
2026-11-10 16:48 · Yahoo
Medicus Pharma Ltd (MDCX) Q3 2026 Earnings Call Highlights: Pfizer ADC License, SkinJet SPAC ...
2026-11-10 05:03 · Yahoo
Medicus Pharma (MDCX) Q3 2026 Earnings Call Transcript
2026-11-09 21:49 · Yahoo
Medicus Pharma sharpens focus on Pfizer-licensed cancer drug CD228V, trims costs in Q3
2026-11-09 13:33 · Yahoo
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
2026-11-09 12:30 · Yahoo
Medicus Pharma Unveils Capital Strategy Centered On Novel Cancer Pipeline
2026-11-09 12:19 · Yahoo
Medicus Pharma Ltd. Common Stock Q3 2026 Earnings Call Summary
2026-11-07 13:30 · Yahoo
Medicus Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-06 21:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.